CAS 1219707-39-7

(R)-3-(3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4(1H)-yl)phenyl)-5-(hydroxymethyl)oxazolidin-2-one

Description:

The chemical substance known as (R)-3-(3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4(1H)-yl)phenyl)-5-(hydroxymethyl)oxazolidin-2-one, with the CAS number 1219707-39-7, is a complex organic compound characterized by its oxazolidinone core structure, which is a five-membered heterocyclic ring containing both oxygen and nitrogen atoms. This compound features a fluorinated phenyl group and a substituted triazine moiety, contributing to its potential biological activity. The presence of the hydroxymethyl group enhances its solubility and reactivity, making it of interest in medicinal chemistry. The specific stereochemistry indicated by the (R) configuration suggests that it may exhibit unique pharmacological properties, potentially influencing its interaction with biological targets. Such compounds are often investigated for their roles as antimicrobial agents or in other therapeutic applications. Overall, the structural complexity and functional groups present in this molecule suggest a diverse range of potential applications in drug development and other fields of chemistry.

Synonyms:

• Tedizolid Intermediate-4

(R)-3-(3-Fluoro-4-(1-Methyl-5,6-Dihydro-1,2,4-Triazin-4(1H)-Yl)Phenyl)-5-(Hydroxymethyl)Oxazolidin-2-One

CAS: 1219707-39-7

(R)-3-(3-Fluoro-4-(1-Methyl-5,6-Dihydro-1,2,4-Triazin-4(1H)-Yl)Phenyl)-5-(Hydroxymethyl)Oxazolidin-2-One

Purity: 98%

Molecular weight: 308.31g/mol

Ref: 54-PC108733

Delpazolid

CAS: 1219707-39-7

Delpazolid

Purity: ≥98%

Molecular weight: 308.31g/mol

Ref: 54-BUP09978

Delpazolid

CAS: 1219707-39-7

Delpazolid (LCB01-0371) is an oxazolidinone that's effective against Gram-positive bacteria and more active than linezolid in systemic infections.

Formula: C₁₄H₁₇FN₄O₃

Purity: 99.62% - 99.69%

Color and Shape: Solid

Molecular weight: 308.31

Ref: TM-T4165

Delpazolid

CAS: 1219707-39-7

Delpazolid is a fatty acid that has been shown to have antimicrobial properties. It inhibits bacterial protein synthesis and is active against a wide range of bacteria. Delpazolid has been shown to inhibit hepg2 cells in vitro, with a concentration-time curve that parallels the growth inhibition of bacteria in vivo. Delpazolid also has a low toxicity profile and is well tolerated by humans. Clinical studies have shown that the drug is rapidly absorbed after oral administration and exhibits linear pharmacokinetics, with plasma concentrations peaking within one hour of ingestion. The drug has been found to be stable in human plasma, but it can react with diphenyl ethers to form a reactive metabolite that reacts with DNA, leading to cell death.

Formula: C₁₄H₁₇FN₄O₃

Purity: Min. 95%

Molecular weight: 308.31 g/mol

Ref: 3D-UYB70739